Today's Low
₹ 372.95
Today's High
₹ 377.55
52 Weeks Low
₹ 372.20
52 Weeks High
₹ 769.15
Lower
₹ 303.35
Upper
₹ 454.95
Sharda Cropchem Limited, a crop protection chemical company, provides various formulations and generic active ingredients worldwide. The company operates through Agrochemicals, and Non-agrochemicals segments. It offers agrochemical products, including insecticides, fungicides, herbicides, veterinary drugs, plant growth regulators, fumigants, regulators, rodenticides, metalaxyl, propiconazole, phenthoate, pendimethalin, and dithianon; and biocides. The company also provides conveyor belts, such as textile ply, rough top, steel cord, chevron/pattern, elevator, sidewall, pipe, and PVC/PVG solid woven conveyor belts, as well as cotton transmission belts, PVC and polyurethane light duty belting products, and V-belts for use in mining projects, steel plants, quarries, grain silos, cement manufacturing facilities, ports, tunneling projects, etc. In addition, it offers organic and inorganic chemicals used in water treatment, food and food ingredients, and other industrial applications; and dyes and dye intermediates, as well as general chemicals. Sharda Cropchem Limited was founded in 1987 and is based in Mumbai, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 3,314.1 | 2,852.6 | 2,099.9 | 1,681.2 | 1,548.2 | 1,639.0 | 1,209.0 | 1,015.5 | 763.8 | 682.9 | 615.5 | 497.3 |
Total Non-Current Assets | 1,561.6 | 1,363.1 | 1,161.2 | 1,013.7 | 961.6 | 891.1 | 669.5 | 513.5 | 409.8 | 231.3 | 178.6 | 135.8 |
Total Assets | 4,875.7 | 4,215.7 | 3,261.1 | 2,694.9 | 2,509.7 | 2,530.1 | 1,878.5 | 1,528.9 | 1,173.5 | 914.2 | 794.1 | 633.1 |
Total Current Liabilities | 2,026.5 | 1,692.9 | 1,139.9 | 856.4 | 821.7 | 1,078.2 | 662.7 | 542.0 | 370.0 | 348.0 | 319.6 | 235.6 |
Total Non-Current Liabilities | 616.8 | 610.0 | 506.6 | 435.4 | 403.9 | 316.8 | 256.0 | 181.4 | 149.1 | 10.4 | 8.6 | 5.0 |
Shareholder's Funds | 2,232.0 | 1,912.5 | 1,614.3 | 1,402.8 | 1,283.9 | 1,134.8 | 959.8 | 805.5 | 654.5 | 555.7 | 466.0 | 392.5 |
Total Liabilities | 4,875.7 | 4,215.7 | 3,261.1 | 2,694.9 | 2,509.7 | 2,530.1 | 1,878.5 | 1,528.9 | 1,173.5 | 914.2 | 794.1 | 633.1 |
The Industry Quick Ratio stands at 1.58, vs the Quick Ratio of 1.52, which results in a Negative aspect.
The Industry Current Ratio stands at 2.23, vs the Current Ratio of 1.96, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.39, vs the Debt to Equity Ratio of 0.00, which results in a Positive aspect.
The Industry Price to BV stands at 4.83, vs the Price to BV of 1.63, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Income | 4,045.2 | 3,579.8 | 2,395.6 | 2,003.0 | 1,997.6 | 1,706.6 | 1,399.2 | 1,222.1 | 1,061.1 | 790.4 | 776.1 | 612.9 |
Total Expenditure | 3,386.4 | 2,884.1 | 1,965.3 | 1,708.1 | 1,663.5 | 1,350.8 | 1,077.6 | 942.9 | 881.8 | 631.0 | 636.8 | 491.0 |
Operating Profit(Excl OI) | 699.0 | 724.6 | 496.1 | 338.0 | 354.6 | 372.4 | 337.3 | 304.7 | 208.0 | 192.2 | 154.2 | 128.5 |
Add: Other Income | 40.3 | 28.9 | 65.8 | 43.1 | 20.6 | 16.6 | 15.7 | 25.5 | 28.7 | 32.8 | 14.9 | 6.6 |
Operating Profit | 699.0 | 724.6 | 496.1 | 338.0 | 354.6 | 372.4 | 337.3 | 304.7 | 208.0 | 192.2 | 154.2 | 128.5 |
Less: Interest | 20.2 | 15.0 | 16.2 | 16.0 | 20.2 | 15.3 | 9.3 | 8.3 | 9.3 | 7.9 | 0.4 | 0.1 |
PBDT | 678.9 | 709.6 | 479.9 | 322.0 | 334.4 | 357.1 | 328.0 | 296.3 | 198.7 | 184.3 | 153.8 | 128.4 |
Less: Depreciation Amortization | 248.1 | 245.3 | 170.4 | 137.1 | 99.4 | 69.9 | 56.3 | 35.1 | 23.3 | 28.9 | 36.7 | 42.7 |
PBT & Exceptional Items | 430.7 | 464.2 | 309.5 | 184.9 | 235.0 | 287.2 | 271.8 | 261.3 | 175.4 | 155.4 | 117.2 | 85.6 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 430.7 | 464.2 | 309.5 | 184.9 | 235.0 | 287.2 | 271.8 | 261.3 | 175.4 | 155.4 | 117.2 | 85.6 |
Less: Taxation | 88.8 | 115.0 | 80.2 | 20.2 | 58.7 | 96.4 | 81.4 | 86.1 | 52.4 | 44.3 | 33.2 | 17.6 |
Profit After Tax | 342.0 | 349.3 | 229.2 | 164.7 | 176.3 | 190.8 | 190.4 | 175.2 | 123.0 | 111.1 | 83.9 | 68.1 |
Earnings Per Share | 0.4 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.9 | 0.0 |
The Industry PAT Margin stands at 11.44, vs the PAT Margin of 8.22, which results in a Negative aspect.
The Industry PAT Growth stands at 31.48, vs the PAT Growth of -6.61, which results in a Negative aspect.
The Industry PE Ratio stands at 30.69, vs the PE Ratio of 39.21, which results in a Positive aspect.
The Industry Dividend Yield stands at 0.76, vs the Dividend Yield of 1.58, which results in a Positive aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 430.7 | 464.2 | 309.5 | 184.9 | 235.0 | 287.2 | 271.8 | 261.3 | 175.9 | 156.8 | 117.2 | 85.6 |
Tax Paid | -65.3 | -74.8 | -57.5 | -62.5 | -80.8 | -79.7 | -56.1 | -69.3 | -60.6 | -40.2 | -40.1 | -27.6 |
Adjustment | 266.5 | 256.9 | 162.9 | 193.9 | 147.0 | 85.0 | 40.8 | 7.9 | 3.6 | 29.1 | 40.4 | 42.7 |
Changes In Working Capital | 430.7 | 464.2 | 309.5 | 184.9 | 235.0 | 287.2 | 271.8 | 261.3 | 175.9 | 156.8 | 117.2 | 85.6 |
Cash Flow after changes in Working Capital | 393.5 | 341.9 | 303.9 | 208.8 | 636.9 | 96.7 | 237.6 | 265.9 | 107.1 | 198.0 | 123.9 | 66.4 |
Cash Flow from Operating Activities | 328.3 | 267.1 | 246.4 | 146.3 | 556.1 | 17.0 | 181.5 | 196.6 | 46.1 | 156.3 | 83.7 | 38.8 |
Cash Flow from Investing Activities | -145.2 | -207.9 | -281.6 | -67.8 | -359.8 | -162.8 | -103.6 | -120.3 | -21.8 | -150.8 | -112.5 | -46.8 |
Cash Flow from Financing Activities | -97.1 | -91.0 | 43.4 | -59.7 | -215.4 | 132.2 | -37.9 | -88.9 | -24.3 | -21.9 | 31.7 | -0.4 |
Net Cash Inflow / Outflow | 86.0 | -31.7 | 8.1 | 18.8 | -19.1 | -13.6 | 40.1 | -12.5 | 0.0 | -16.4 | 2.9 | -8.3 |
Opening Cash & Cash Equivalents | 56.7 | 85.6 | 77.8 | 50.6 | 61.2 | 72.2 | 32.3 | 38.0 | 21.6 | 32.3 | 29.6 | 23.0 |
Closing Cash & Cash Equivalent | 176.4 | 56.7 | 85.6 | 77.8 | 50.6 | 61.3 | 72.2 | 32.3 | 24.8 | 21.6 | 32.5 | 29.6 |
The Industry PFCF Ratio stands at 14.72, vs the PFCF Ratio of -22.00, which results in a Negative aspect.
The Industry PCF RATIO stands at 29.74, vs the PCF RATIO of 6.63, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 6,324.6 | 5,807.6 | 6,377.5 | 14,818.3 | 10,173.0 | 7,215.0 | 8,245.3 | 14,345.0 | 8,798.1 | 6,427.8 | 6,226.8 | 10,881.4 | 4,938.1 | 4,247.6 | 3,889.0 | 8,755.6 |
Total Income | 6,674.3 | 6,043.5 | 6,732.7 | 14,888.7 | 10,200.4 | 7,317.5 | 8,447.8 | 14,371.5 | 8,867.2 | 6,556.3 | 6,406.2 | 11,049.0 | 5,160.8 | 4,412.6 | 4,123.4 | 8,858.3 |
Total Expenditure | 5,857.9 | 5,595.7 | 7,065.2 | 11,635.9 | 8,103.8 | 6,564.4 | 7,716.5 | 11,442.2 | 6,914.6 | 5,530.4 | 5,196.3 | 8,849.9 | 3,975.8 | 3,679.8 | 3,413.6 | 7,122.4 |
PBIDT (Excl OI) | 466.8 | 211.9 | -687.7 | 3,182.3 | 2,069.2 | 650.6 | 528.8 | 2,902.8 | 1,883.6 | 897.4 | 1,030.5 | 2,031.5 | 962.3 | 567.8 | 475.4 | 1,633.3 |
Other Income | 349.7 | 235.9 | 355.2 | 70.4 | 27.4 | 102.5 | 202.5 | 26.6 | 69.1 | 128.5 | 179.5 | 167.6 | 222.7 | 165.0 | 234.4 | 102.6 |
Operating Profit | 816.4 | 447.8 | -332.5 | 3,252.8 | 2,096.6 | 753.1 | 731.3 | 2,929.3 | 1,952.6 | 1,025.9 | 1,210.0 | 2,199.1 | 1,185.0 | 732.7 | 709.8 | 1,735.9 |
Interest | 9.0 | 46.5 | 12.9 | 24.8 | 9.1 | 3.6 | 7.6 | 7.3 | 4.3 | 4.4 | 6.1 | 7.7 | 4.5 | 7.3 | 8.3 | 4.5 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 807.5 | 401.3 | -345.4 | 3,228.0 | 2,087.5 | 749.4 | 723.7 | 2,922.0 | 1,948.3 | 1,021.5 | 1,203.9 | 2,191.4 | 1,180.6 | 725.5 | 701.5 | 1,731.4 |
Depreciation | 686.3 | 739.7 | 702.8 | 676.6 | 653.2 | 604.0 | 547.3 | 717.4 | 590.4 | 606.4 | 539.2 | 522.2 | 404.3 | 423.2 | 354.6 | 350.1 |
Profit Before Tax | 121.2 | -338.4 | -1,048.2 | 2,551.4 | 1,434.3 | 145.4 | 176.4 | 2,204.7 | 1,357.9 | 415.1 | 664.7 | 1,669.2 | 776.2 | 302.3 | 346.9 | 1,381.4 |
Tax | 74.7 | -62.5 | -161.8 | 562.8 | 350.3 | 24.6 | -50.1 | 434.8 | 336.0 | 94.9 | 284.0 | 329.9 | 293.3 | 111.5 | 67.7 | -35.5 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 46.4 | -275.8 | -886.4 | 1,988.5 | 1,084.0 | 120.8 | 226.4 | 1,769.9 | 1,021.9 | 320.2 | 380.7 | 1,339.3 | 483.0 | 190.7 | 279.2 | 1,416.8 |
Net Profit | 46.4 | -275.8 | -886.4 | 1,988.5 | 1,084.0 | 120.8 | 226.4 | 1,769.9 | 1,021.9 | 320.2 | 380.7 | 1,339.3 | 483.0 | 190.7 | 279.2 | 1,416.8 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 902.2 | 902.2 | 902.2 | 902.2 | 902.2 | 902.2 | 902.2 | 902.2 | 902.2 | 902.2 | 902.2 | 902.2 | 902.2 | 902.2 | 902.2 | 902.2 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 0.5 | -3.1 | -9.8 | 22.0 | 12.0 | 1.3 | 2.5 | 19.6 | 11.3 | 3.6 | 4.2 | 14.8 | 5.4 | 2.1 | 3.1 | 15.7 |
Operating Profit Margin | 12.9 | 7.7 | -5.2 | 22.0 | 20.6 | 10.4 | 8.9 | 20.4 | 22.2 | 16.0 | 19.4 | 20.2 | 24.0 | 17.3 | 18.3 | 19.8 |
Net Profit Margin | 0.7 | -4.7 | -13.9 | 13.4 | 10.7 | 1.7 | 2.7 | 12.3 | 11.6 | 5.0 | 6.1 | 12.3 | 9.8 | 4.5 | 7.2 | 16.2 |
The Industry Net Sales Growth stands at 22.11, vs the Net Sales Growth of 0.27, which results in a Negative aspect.
The Industry Mcap Growth stands at 336.25, vs the Mcap Growth of -71.13, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 394.25 | 400.59 | 383.30 |
R3 | 389.67 | 390.48 | 381.23 |
R2 | 385.08 | 385.49 | 380.53 |
R1 | 382.12 | 382.93 | 379.84 |
Pivot | 377.53 | 377.94 | 377.53 |
S1 | 374.57 | 375.38 | 378.46 |
S2 | 369.98 | 370.39 | 377.77 |
S3 | 367.02 | 367.83 | 377.07 |
S4 | 364.05 | 355.29 | 375.00 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
78.73
Neutral
RSI
56.90
Neutral
ROC
3.20
Bullish
UltimateOscillator
62.02
Neutral
Williams Indicator
-12.99
Bearish
CCI Indicator
82.06
Neutral
MACD
-2,646.63
Bearish
Stochastic Indicator
82.21
Neutral
ATR
14.15
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
01-08-2023 | 3.00 | 30 | Final |
07-02-2023 | 3.00 | 30 | Interim |
25-07-2022 | 3.00 | 30 | Final |
02-02-2022 | 3.00 | 30 | Interim |
20-07-2021 | 3.00 | 30 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
24-01-2024 | Quarterly Results |
21-10-2023 | Quarterly Results |
24-07-2023 | Quarterly Results |
12-05-2023 | Final Dividend & Audited Results |
24-01-2023 | Quarterly Results & Interim Dividend |
21-10-2022 | Quarterly Results |
25-07-2022 | Quarterly Results |
13-05-2022 | Audited Results & Final Dividend |
22-01-2022 | 538666 Sharda Cropchem Limited 22/01/2022 Quarterly Results & Interim Dividend |
22-01-2022 | Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2022 ,inter alia, to consider and approve We wish to inform you that the meeting of the Board of Directors of our Company is scheduled to be held on Saturday, January 22, 2022, inter-alia to consider, approve & take on record the Un-audited Financial Results (Standalone and Consolidated) for the quarter & nine months ended December 31, 2021 and to consider & declare Interim Dividend, if any, on the paid-up equity share capital of the Company for the Financial Year 2021-22. Further, in continuation to our disclosure on Closure of Trading Window dated December 31, 2021, pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading in the shares of the Company, we would like to inform that the Trading Window for dealing in shares of the Company shall remain closed for all designated employees and connected persons of the Company till January 24, 2022. |
26-10-2021 | Quarterly Results |
27-07-2021 | Quarterly Results |
26-05-2021 | Final Dividend & Audited Results |